Jarneborn, A.;                     Hu, Z.;                     Deshmukh, M.;                     Kopparapu, P.K.;                     Jin, T.    
        Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. Int. J. Mol. Sci. 2024, 25, 7456.
    https://doi.org/10.3390/ijms25137456
    AMA Style
    
                                Jarneborn A,                                 Hu Z,                                 Deshmukh M,                                 Kopparapu PK,                                 Jin T.        
                Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. International Journal of Molecular Sciences. 2024; 25(13):7456.
        https://doi.org/10.3390/ijms25137456
    
    Chicago/Turabian Style
    
                                Jarneborn, Anders,                                 Zhicheng Hu,                                 Meghshree Deshmukh,                                 Pradeep Kumar Kopparapu,                                 and Tao Jin.        
                2024. "Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock" International Journal of Molecular Sciences 25, no. 13: 7456.
        https://doi.org/10.3390/ijms25137456
    
    APA Style
    
                                Jarneborn, A.,                                 Hu, Z.,                                 Deshmukh, M.,                                 Kopparapu, P. K.,                                 & Jin, T.        
        
        (2024). Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. International Journal of Molecular Sciences, 25(13), 7456.
        https://doi.org/10.3390/ijms25137456